BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fabisiak N, Fabisiak A, Chmielowiec-Korzeniowska A, Tymczyna L, Kamysz W, Kordek R, Bauer M, Kamysz E, Fichna J. Anti-inflammatory and antibacterial effects of human cathelicidin active fragment KR-12 in the mouse models of colitis: a novel potential therapy of inflammatory bowel diseases. Pharmacol Rep 2021;73:163-71. [PMID: 33219923 DOI: 10.1007/s43440-020-00190-3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
Number Citing Articles
1 Gubatan J, Holman DR, Puntasecca CJ, Polevoi D, Rubin SJ, Rogalla S. Antimicrobial peptides and the gut microbiome in inflammatory bowel disease. World J Gastroenterol 2021; 27(43): 7402-7422 [PMID: 34887639 DOI: 10.3748/wjg.v27.i43.7402] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
2 Rivas-Santiago B, Jacobo-Delgado Y, Rodriguez-Carlos A. Are Host Defense Peptides and Their Derivatives Ready to be Part of the Treatment of the Next Coronavirus Pandemic? Arch Immunol Ther Exp (Warsz) 2021;69:25. [PMID: 34529143 DOI: 10.1007/s00005-021-00630-9] [Reference Citation Analysis]